Pharma Journalist -

CorePharma acquired by Investor Group, its facilities and equipment in Middlesex, NJ from Impax Laboratories. Financial terms of the acquisition were not disclosed. The acquisition does…
Read More...

Microbiome comapany developing customized phage therapies , BiomX Ltd. declared that it has sought sub-license from JSR Corporation a set of bacterial targets for the development and…
Read More...

Clinical-stage biotechnology company,devoted to treating inflammation and inborn errors of metabolism, Aldeyra Therapeutics enrolled first patient in a Phase 2b Clinical Trial of …
Read More...

Upsher-Smith Laboratories, LLC  declared that it sought U.S Food and Drug Administration's approval for new drug application (ANDA) for Bumetanide Tablets, USP, 0.5 mg, 1 mg, and 2 mg,…
Read More...

Industry leader in orthopaedic devices using advanced functional materials, MedShape declared successful performance of first surgeries using DynaNail XL TTC Fusion System.  The…
Read More...

Mallinckrodt plc affirmed enrolling first patient in the company's Phase 4, multi center, randomized, double-blind, placebo-controlled pilot study to facilitate evaluation of the…
Read More...

U.S  Food and Drug Administration conceded to Multi  Radiance Medical's MR4 Laser technology for neck and shoulder pain relief under the Product Classification NHN. MR4 Laser technology…
Read More...

Takeda Pharmaceutical company Limited asserted that the U.S Food and Drug Administration has extended Fast Track designation to TAK-426 i.e Takeda's Zika virus vaccine candidate. …
Read More...

European Organisation for Research and Treatment of Cancer (EORTC) and Foundation Medicine collaborate to ascertain eligibility of patients for oncology clinical Trials of  Foundation…
Read More...

In a bid to commercialize NERLYNX, Puma Biotechnology and Medison Pharma have forayed into an exclusive licensing agreement in Israel as it is currently not approved for…
Read More...